Kaleido Biosciences, Inc.
KLDO
$0.002
$0.00191,900.00%
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Net Income | 12.19% | 3.37% | -3.68% | -15.12% | 13.47% |
| Total Depreciation and Amortization | 1.68% | 1.89% | 1.04% | 2.49% | 24.83% |
| Total Amortization of Deferred Charges | 2.91% | -0.58% | -5.46% | -29.34% | 48.85% |
| Total Other Non-Cash Items | -20.96% | -15.06% | -46.38% | 58.48% | -36.84% |
| Change in Net Operating Assets | -83.29% | 551.32% | 111.13% | -219.66% | 214.53% |
| Cash from Operations | -8.08% | 20.94% | 16.23% | -112.22% | 31.39% |
| Capital Expenditure | -1.16% | -85.78% | -673.33% | 95.47% | 54.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.46% | -85.78% | -673.33% | 95.47% | 54.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 0.00% | -91.07% | -99.92% | 1,786.53% | 156.22% |
| Repurchase of Common Stock | -57.89% | 81.73% | 44.09% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | -78.57% | 79.41% | -100.10% | 1,822.28% | 154.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.28% | 19.92% | -144.18% | 655.23% | 49.64% |